ロード中...
Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy
INTRODUCTION: Desvenlafaxine, the active metabolite of venlafaxine, is a serotonin norepinephrine reuptake inhibitor (SNRI) recently approved for the treatment of major depressive disorder. It is one of only three medications in this class available in the United States. AIMS: The objective of this...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2899788/ https://ncbi.nlm.nih.gov/pubmed/20694066 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|